
Bridget E. Bunner
Examiner (ID: 19030, Phone: (571)272-0881 , Office: P/1647 )
| Most Active Art Unit | 1647 |
| Art Unit(s) | 1644, 1647 |
| Total Applications | 1463 |
| Issued Applications | 725 |
| Pending Applications | 157 |
| Abandoned Applications | 602 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8745538
[patent_doc_number] => 20130085255
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'Process for Preparing Caprolactam and Polyamides Therefrom'
[patent_app_type] => utility
[patent_app_number] => 13/442306
[patent_app_country] => US
[patent_app_date] => 2012-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19825
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13442306
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/442306 | Process for preparing caprolactam and polyamides therefrom | Apr 8, 2012 | Issued |
Array
(
[id] => 8442379
[patent_doc_number] => 20120258995
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-11
[patent_title] => 'New Indolinone Protein Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/441813
[patent_app_country] => US
[patent_app_date] => 2012-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3484
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13441813
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/441813 | Indolinone protein kinase inhibitors | Apr 5, 2012 | Issued |
Array
(
[id] => 8767030
[patent_doc_number] => 20130095066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-18
[patent_title] => 'Compounds for the Treatment of Hepatitis C'
[patent_app_type] => utility
[patent_app_number] => 13/440003
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8494
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13440003
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/440003 | Compounds for the treatment of hepatitis C | Apr 4, 2012 | Issued |
Array
(
[id] => 8324448
[patent_doc_number] => 20120196855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'OXYGEN LINKED PYRIMIDINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/438989
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33101
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13438989
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/438989 | Oxygen linked pyrimidine derivatives | Apr 3, 2012 | Issued |
Array
(
[id] => 8429706
[patent_doc_number] => 20120251581
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'Novel Compound and Methods for its Production'
[patent_app_type] => utility
[patent_app_number] => 13/433944
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 22413
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13433944
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/433944 | Compound and methods for its production | Mar 28, 2012 | Issued |
Array
(
[id] => 8896735
[patent_doc_number] => 08476256
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Diazonamide analogs'
[patent_app_type] => utility
[patent_app_number] => 13/430555
[patent_app_country] => US
[patent_app_date] => 2012-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 26658
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13430555
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/430555 | Diazonamide analogs | Mar 25, 2012 | Issued |
Array
(
[id] => 8756026
[patent_doc_number] => 20130090331
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-11
[patent_title] => 'TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASE'
[patent_app_type] => utility
[patent_app_number] => 13/429826
[patent_app_country] => US
[patent_app_date] => 2012-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22920
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13429826
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/429826 | TRICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF JANUS KINASE | Mar 25, 2012 | Abandoned |
Array
(
[id] => 8429687
[patent_doc_number] => 20120251560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'CONJUGATED LIPOMERS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/428695
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 39767
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13428695
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/428695 | Conjugated lipomers and uses thereof | Mar 22, 2012 | Issued |
Array
(
[id] => 8278553
[patent_doc_number] => 20120172422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'Methods of Treatment Using a Prodrug of an Excitatory Amino Acid'
[patent_app_type] => utility
[patent_app_number] => 13/418613
[patent_app_country] => US
[patent_app_date] => 2012-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48825
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13418613
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/418613 | Methods of Treatment Using a Prodrug of an Excitatory Amino Acid | Mar 12, 2012 | Abandoned |
Array
(
[id] => 9074607
[patent_doc_number] => 08552186
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-08
[patent_title] => 'Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/413322
[patent_app_country] => US
[patent_app_date] => 2012-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 592613
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13413322
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/413322 | Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors | Mar 5, 2012 | Issued |
Array
(
[id] => 8265924
[patent_doc_number] => 20120165351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'QUINAZOLINE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/410448
[patent_app_country] => US
[patent_app_date] => 2012-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74476
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13410448
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/410448 | QUINAZOLINE DERIVATIVES | Mar 1, 2012 | Abandoned |
Array
(
[id] => 8265901
[patent_doc_number] => 20120165341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'THERAPEUTIC AGENT FOR SENILE DEMENTIA'
[patent_app_type] => utility
[patent_app_number] => 13/409075
[patent_app_country] => US
[patent_app_date] => 2012-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4045
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13409075
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/409075 | Therapeutic agent for senile dementia | Feb 28, 2012 | Issued |
Array
(
[id] => 8251906
[patent_doc_number] => 20120156219
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/402033
[patent_app_country] => US
[patent_app_date] => 2012-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 117558
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20120156219.pdf
[firstpage_image] =>[orig_patent_app_number] => 13402033
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/402033 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF | Feb 21, 2012 | Abandoned |
Array
(
[id] => 8348077
[patent_doc_number] => 20120208997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-16
[patent_title] => 'NOVEL COMPOUND HAVING HETEROCYCLIC RING'
[patent_app_type] => utility
[patent_app_number] => 13/372848
[patent_app_country] => US
[patent_app_date] => 2012-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51857
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372848
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/372848 | Compound having heterocyclic ring | Feb 13, 2012 | Issued |
Array
(
[id] => 10026063
[patent_doc_number] => 09067949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-30
[patent_title] => 'Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia'
[patent_app_type] => utility
[patent_app_number] => 13/352864
[patent_app_country] => US
[patent_app_date] => 2012-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84830
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13352864
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/352864 | Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia | Jan 17, 2012 | Issued |
Array
(
[id] => 8186778
[patent_doc_number] => 20120115890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'SOLID FORMS COMPRISING 4-[9-(TETRAHYDRO-FURAN-3-YL)-8-(2,4,6-TRIFLUORO-PHENYLAMINO)-9H-PURIN-2-YLAMINO]-CYCLOHEXAN-1-OL, COMPOSITIONS THEREOF, AND USES THEREWITH'
[patent_app_type] => utility
[patent_app_number] => 13/348825
[patent_app_country] => US
[patent_app_date] => 2012-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 22770
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0115/20120115890.pdf
[firstpage_image] =>[orig_patent_app_number] => 13348825
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/348825 | SOLID FORMS COMPRISING 4-[9-(TETRAHYDRO-FURAN-3-YL)-8-(2,4,6-TRIFLUORO-PHENYLAMINO)-9H-PURIN-2-YLAMINO]-CYCLOHEXAN-1-OL, COMPOSITIONS THEREOF, AND USES THEREWITH | Jan 11, 2012 | Abandoned |
Array
(
[id] => 8916992
[patent_doc_number] => 20130178618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'NOVEL PHARMACEUTICAL INTERMEDIATES AND METHODS FOR PREPARING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/346815
[patent_app_country] => US
[patent_app_date] => 2012-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5122
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13346815
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/346815 | NOVEL PHARMACEUTICAL INTERMEDIATES AND METHODS FOR PREPARING THE SAME | Jan 9, 2012 | Abandoned |
Array
(
[id] => 9280274
[patent_doc_number] => 20140030242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-30
[patent_title] => 'ANTIFUNGAL COMPOSITION COMPRISING POLYCYCLIC PEPTIDE COMPOUND AND METHOD FOR PREPARING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 13/978488
[patent_app_country] => US
[patent_app_date] => 2012-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5244
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978488
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978488 | Antifungal composition comprising polycyclic peptide compound and method for preparing the same | Jan 3, 2012 | Issued |
Array
(
[id] => 9455509
[patent_doc_number] => 08716518
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-06
[patent_title] => 'Photoacid generating monomer and precursor thereof'
[patent_app_type] => utility
[patent_app_number] => 13/340088
[patent_app_country] => US
[patent_app_date] => 2011-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7732
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13340088
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/340088 | Photoacid generating monomer and precursor thereof | Dec 28, 2011 | Issued |
Array
(
[id] => 8381462
[patent_doc_number] => 20120225089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'NOVEL CONJUGATES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/331259
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 49967
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13331259
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/331259 | Conjugates, preparation thereof, and therapeutic use thereof | Dec 19, 2011 | Issued |